Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-4.08%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-24.65%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-32.54%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-40.04%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-25.94%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range46.86 - 90.86 Perf YTD-30.93%
Dividend0.41 P/FCF- EPS past 5Y- ROI- 52W High-46.63% Beta-
Dividend %0.85% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low3.48% ATR3.04
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)31.20 Volatility5.50% 6.38%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.59 Prev Close50.38
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.54M Price48.49
Recom- SMA20-10.40% SMA50-23.33% SMA200-33.06% Volume8,664,500 Change-3.75%
Feb-06-16 12:01AM  [$$] Celgene and Gilead: Two Drugmakers, 30% Upside at
Feb-05-16 11:02AM  Some biotechnology stocks that provide clear opportunities, J.P. Morgan says at MarketWatch
09:48AM  ETFs to Play a Pop in Biotech M&A at
Feb-03-16 01:05PM  Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits High
12:48PM  TickerTags Data Shows Drug Price Debate Still Trending
10:17AM  3 Biotech ETFs With Bear-Killing Magic at TheStreet
Feb-02-16 05:40PM  Why Regeneron Pharmaceuticals Shares Fell 23% in January at Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund
Jan-31-16 02:46PM  Tracking The Biotech Bubble's Bust at Forbes
Jan-29-16 01:17PM  If history rhymes this indicator suggests stocks still have a long way to fall
09:30AM  The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Bullish Fund, SPDR S&P Biotech ETF, SPDR S&P Regional Banking ETF and SPDR Gold Shares
Jan-28-16 11:37AM  ETF Winners & Losers Post Fed Meet
Jan-22-16 08:07AM  Revlimid Continues to Drive Celgenes Revenue
07:11AM  Even With Volatility, Investors Love Biotech ETFs
Jan-20-16 03:53PM  Chimerix Inc. Is Roaring Higher Again -- Here's Why at Motley Fool
Jan-19-16 08:47AM  Calls bet on quick pop in biotech fund
Jan-18-16 08:59AM  Bloodied Biotech Stocks Had It Coming, But Check Out This Chart at Forbes
Jan-16-16 09:12AM  Biotech Investing: This Is Undoubtedly the Craziest Stat You'll Ever See at Motley Fool
Jan-15-16 07:41PM  Index ETFs Gouged, With S&P 500, Dow In Correction at Investor's Business Daily
Jan-14-16 02:06PM  Is it time to bet on biotech?
Jan-13-16 12:29PM  Investor Apathy Keeps Biotech Stocks in the Red at TheStreet -6.94%
Jan-12-16 01:05PM  Tuesday links: commodity fundamentals
07:20AM  Betting On A Biotech Bounce With A Familiar ETF
06:00AM  Biotech & Industrials: Two ETFs Trading with Outsized Volume
Jan-11-16 01:26PM  Monday links: being in cash -5.57%
07:14AM  Short-term ceiling seen in biotech fund
07:00AM  The Trader Daily: The Sharpest Rallies Occur in Bear Markets
Jan-08-16 05:55PM  What Lies Ahead for Biotech ETFs in 2016?
Jan-05-16 05:15PM  The Best Sectors To Sell Short in 2016 at Investopedia
Dec-30-15 01:27PM  Wednesday links: better track records
Dec-29-15 05:06PM  4 reasons it may be time to take a break from biotech
12:19PM  Biotech ETFs Rally, Oil & Gas ETFs Gush at Investor's Business Daily
06:59AM  The Best ETFs for 2016 at Motley Fool
Dec-28-15 07:14AM  2016 biotech and pharma predictions
12:05AM  Ionis Pharmaceuticals Initiates Phase 2 Study, Trades above 100-Day Moving Average on December 17
12:05AM  Mimedx Group Issues 2016 Guidance, SPDR S&P Biotech Small-Caps Thread the Needle
Dec-26-15 11:11AM  XBI: SPDR S&P Biotech ETF at Investopedia
Dec-25-15 12:05AM  Alnylam Initiates Clinical Trial, SPDR S&P Biotech Mid-Caps Plunge Anyway
Dec-23-15 12:29PM  3 ETF Winners Post Fed Rate Hike
Dec-21-15 02:07PM  XBI Recovers from Its Slump
Dec-19-15 10:36AM  Last Week's Best Healthcare ETF at Motley Fool
Dec-18-15 04:40PM  Profit Booking Hobbles the SPDR S&P Biotech ETFs Large-Caps on December 17
04:40PM  The SPDR S&P Biotech ETF Buckles as Mid-Caps and Large-Caps Slump on December 17
Dec-16-15 08:30AM  Joe Friday had his eye on Valeant (VRX) and it delivered (up 45%)
Dec-14-15 01:08PM  Commodities Fell, XBI Was the Weaker Biotech ETF
01:07PM  Anacor Moves up on Buying Support, Leads XBIs Mid-Cap Stocks
Dec-11-15 03:22PM  Alexion Continues to Rise on FDAs Approval of Kanuma
03:22PM  XBI Remains on Shaky Ground
07:06AM  How Gilead's Dividend Can Inject Cash and Growth in Your Portfolio at TheStreet
Dec-10-15 09:38AM  November's Best Healthcare ETF at Motley Fool
06:50AM  Genome sequencing: A glimpse of the future
Dec-09-15 02:54PM  Drug price probe
12:58PM  Top trades for the 2nd half: Oil & biotechs
Dec-08-15 11:00AM  An Open Letter About Todays Market Environment 12-8-15
Dec-07-15 03:45PM  Sangamo Rises on FDA Clearance, Leads IHI Small-Caps
03:44PM  IHF Sustains the Biotech Sell-off, Loses Marginally
Dec-05-15 08:30PM  The scariest investment trend of the next century
07:40AM  These 3 ETFs Jumped in November at Motley Fool
Dec-04-15 11:28AM  The SPDR S&P Biotech ETF Lingers in the Red as of December 3
Dec-02-15 02:05AM  Immunogen Topped the Small-Cap Stocks with High Volumes
Dec-01-15 07:40AM  Another Visit With A Leveraged Biotech ETF
06:09AM  XBI Tops Biotech ETFs for the Week Ended November 27
Nov-30-15 09:34AM  Last Week's Top Healthcare ETF at Motley Fool
Nov-27-15 08:36AM  Europe Approved Biogens Elocta, Topped XBIs Large-Cap Stocks
08:36AM  XBI Contradicted the Market, Agios Rose by 8.3%
Nov-24-15 09:35PM  Sarepta Rises 5.3%, Helping XBIs Small-Cap Stocks
09:35PM  Radius Falls by 11%, Hindering XBIs Mid-Cap Stock Performance
12:41PM  An Open Letter About Todays Market Environment 11-24-15
11:10AM  Does Recent Biotech Volatility Signal Tougher Times Ahead? at Forbes
08:15AM  Healthcare ETFs' Check Up Ahead Of Higher Interest Rates
Nov-18-15 03:01PM  Amgen Rises by 2% as XBIs Large-Cap Stocks Rally
03:01PM  XBI Rises in Contrast to a Flat Market
Nov-17-15 09:04AM  Arena Rose 14% in XBIs Small-Cap Space
08:56AM  Biotech- Market leader facing breakout level
Nov-10-15 08:06AM  Dyax and Acadia Drove XBIs Mid-Cap Space
08:05AM  Vertex Reported Its 3Q15 Earnings: Stock Rose 5%
07:05AM  Buy Amgen's Healthy Dividend, Hold for Its Growth Prescription at TheStreet
Nov-09-15 01:37PM  Regulus Was Last Weeks Top Biotech Performer
08:03AM  Equal Weighting Works For This Industry ETF
Nov-07-15 12:07AM  AbbVie Topped XBIs Large-Cap Space
12:07AM  Moving Averages of XBIs Holdings Have Improved
Nov-06-15 01:02PM  Biotech: 'That Was Fun While It Lasted' at
11:10AM  Heres where youll find the next tech bubble at MarketWatch
Nov-05-15 03:42PM  Chinese economy stabilizing: Ulrich
03:39PM  30 minutes to close: Unusual volume
Nov-02-15 05:00PM  United Therapeutics Led the Biotechnology Subgroup for the Week +6.53%
07:34AM  3 Stocks to Buy Now in Biotech at Motley Fool
Nov-01-15 04:09PM  The Top 3 Biotech ETFs on the Market at Motley Fool
Oct-30-15 11:25AM  Amgen Reported Its 3Q15 Earnings: Stock Fell by 1.3%
11:24AM  XBI Fell the Most as the Small-Caps Took a Hit
08:19AM  Why biotech could be on the verge of a rebound
Oct-29-15 01:04AM  Opko Outperforms in XBIs Mid-Cap Space
Oct-28-15 03:12PM  Traders Get Adventurous With Leveraged Biotech ETFs
Oct-24-15 02:06PM  Baxalta in the XBI Top Ten Large Caps
02:04PM  The Bottom Ten Stocks of XBI Outperform on October 8
Oct-23-15 10:54AM  Talking Earnings Season With Estimize
01:05AM  Alnylam Up 2.0% on Phase 1 Initiation of OLE Study with ALT-AT3
Oct-19-15 06:57PM  Airlines ETF Zips Ahead; Tech ETFs Eye Amazon at Investor's Business Daily
09:10AM  Insight: Five Prime Therapeutics
09:05AM  Overview: Biotechnology companies Post Impressive Gains
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.